US4556557A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and composition for combating snoring, and the use of surface active substances for the preparation of said composition
Assignee: Individual
•
Filing: 1983-07-15
•
Granted: 1985-12-03
•
Expires: 2003-07-15
Abstract
Abstract A composition for overcoming snoring as well as a process for its use is disclosed. The composition according to the invention contains a surface active substance, a preserving agent and/or a substance acting bactericidally or fungicidally on the mucous membranes and optionally a substance for softening the mucous membranes in physiological common salt solution as well as optionally further additives which are compatible with the mucous membranes.
Inventors
- 👤 Dietrich Reichert
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 19:24
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0043; A61K31/00; A61K31/13; A61K31/14; A61P; A61P43/00
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
89 words
A method of combating snoring, which comprises administering to a snoring victim's nasopharyngeal mucous membranes, shortly prior to his or her retiring for sleep, a composition containing (a) 0.05 to 2% by weight of a non-ionic surface active substance compatible with the mucous membranes and largely free of undesirable smell and taste and (b) 0.01 to 4% by weight of a pharmaceutically acceptable agent selected from the group consisting of a preserving agent and substances acting bactericidally or fungicidally on the mucous membranes, in a physiological common salt solution.
Claim 2
Independent Claim
89 words
A method of combating snoring, which comprises administering to a snoring victim's nasopharyngeal mucous membranes, shortly prior to his or her retiring for sleep, a composition containing (a) 0.05 to 2% by weight of a non-ionic surface active substance compatible with the mucous membranes and largely free of undesirable smell and taste and (b) 0.01 to 4% by weight of a pharmaceutically acceptable agent selected from the group consisting of a preserving agent and substances acting bactericidally or fungicidally on the mucous membranes, in a physiological common salt solution.
Claim 3
Dependent Claim
25 words
The method according to claim 1, wherein the composition further contains 0.1 to 1% by weight of a softening compound for softening the mucous membranes.
Claim 4
Dependent Claim
32 words
The method according to claim 1, wherein the surface active substance is selected from the group consisting of fatty acid ester of oxyethylated sorbitol, sorbitan, pentaerithritol, lecithins and oxyethylated octylphenol formaldehyde polymers.
Claim 5
Dependent Claim
17 words
The method according to claim 1, wherein the surface active substance is a polyoxyalkylene ester of sorbitan.
Claim 6
Dependent Claim
16 words
The method according to claim 4, wherein the surface active substance is a polyoxyethylene sorbitan monocarboxylate.
Claim 7
Dependent Claim
16 words
The method according to claim 4, wherein the surface active substance is a polyoxyethylene sorbitan monooleate.
Claim 8
Dependent Claim
36 words
The method according to claim 1, wherein the preserving agent is a substance selected from the group consisting of ethanol, esters of p-hydroxybenzoic acid, 2-phenoxy-ethanol benzoic acid and its salts, and sorbic acid and its esters.
Claim 9
Dependent Claim
15 words
The method according to claim 1, wherein the composition contains as said agent benzalkonium chloride.
Claim 10
Dependent Claim
14 words
The method according to claim 1, wherein the composition contains as said agent chlorobutanol.
Claim 11
Dependent Claim
25 words
The method according to claim 2, wherein the softening compound is at least one substance selected from the group consisting of glycerol, sorbitol and panthenol.
Claim 12
Dependent Claim
29 words
The method according to claim 1, wherein the composition contains additionally at least one substance selected from the group consisting of vitamin A, vitamin E, hydrolases, lipases and proteases.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-12-02 | 1989-06-03 | 1989-12-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-12-02 | 1993-06-03 | 1993-12-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-12-02 | 1997-06-03 | 1997-12-03 | $7700.00 | Window Closed / Lapsed |